Sign up to save your podcasts
Or
Share Efficacy and Safety of Rituximab for New-Onset Generalized Myasthenia Gravis
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Efficacy and Safety of Rituximab for New-Onset Generalized Myasthenia Gravis
Dr. Gordon Smith talks with Dr. Fredrik Piehl about the use of rituximab for new-onset generalized myasthenia gravis.
Read the related article in JAMA Neurology.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Disclosures can be found at Neurology.org.
View all episodes
By American Academy of Neurology
4.7
279279 ratings
Dr. Gordon Smith talks with Dr. Fredrik Piehl about the use of rituximab for new-onset generalized myasthenia gravis.
Read the related article in JAMA Neurology.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Disclosures can be found at Neurology.org.
More shows like Neurology® Podcast
View all
JAMA Editors' Summary
135 Listeners
NEJM This Week
316 Listeners
Practical Neurology Podcast
47 Listeners
JAMA Clinical Reviews
498 Listeners
The Curbsiders Internal Medicine Podcast
3,321 Listeners
JAMA Medical News
90 Listeners
Core IM | Internal Medicine Podcast
1,101 Listeners
Neurology Today in 5
23 Listeners
Annals On Call Podcast
194 Listeners
The Clinical Problem Solvers
519 Listeners
Neurology Minute
131 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
350 Listeners
Neurology Exam Prep Podcast
183 Listeners
The Curious Clinicians
366 Listeners
Continuum Audio
79 Listeners